Hyperthermia and Reirradiation

  • Oliver J. Ott
  • Manfred Schmidt
Part of the Medical Radiology book series (MEDRAD)


Quality-assured local and regional hyperthermia procedures have been proven to enhance the clinical benefits of oncological standard treatments in several clinical settings without a substantial increase of late toxicity. This makes hyperthermia an attractive sensitizer for both radiotherapy and chemotherapy. It is no longer the question whether hyperthermia is an effective oncological treatment at all. Currently, the question is which patient, which tumor entity, and which clinical stage of disease benefit most from additional hyperthermia as integral part of current multimodality oncological standard treatment schedules. This remains particularly true for patients with recurrent malignant diseases and a previous irradiation series in the involved area.


Rectal Cancer Complete Remission Rate Recurrent Rectal Cancer Hyperthermia Treatment Chest Wall Recurrence 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Angele MK, Albertsmeier M, Prix NJ, Hohenberger P, Abdel-Rahman S, Dieterle N et al (2014) Effectiveness of regional hyperthermia with chemotherapy for high-risk retroperitoneal and abdominal soft-tissue sarcoma after complete surgical resection: a subgroup analysis of a randomized phase-III multicenter study. Ann Surg 260:749–754; discussion 54–6CrossRefPubMedPubMedCentralGoogle Scholar
  2. Berdov BA, Menteshashvili GZ (1990) Thermoradiotherapy of patients with locally advanced carcinoma of the rectum. Int J Hyperthermia 6:881–890CrossRefPubMedGoogle Scholar
  3. Bruggmoser G, Bauchowitz S, Canters R, Crezee H, Ehmann M, Gellermann J et al (2012) Guideline for the clinical application, documentation and analysis of clinical studies for regional deep hyperthermia: quality management in regional deep hyperthermia. Strahlenther Onkol 188(Suppl 2):198–211CrossRefPubMedGoogle Scholar
  4. Colombo R, Da Pozzo LF, Salonia A, Rigatti P, Leib Z, Baniel J et al (2003) Multicentric study comparing intravesical chemotherapy alone and with local microwave hyperthermia for prophylaxis of recurrence of superficial transitional cell carcinoma. J Clin Oncol 21:4270–4276CrossRefPubMedGoogle Scholar
  5. Cornett WR, McCall LM, Petersen RP, Ross MI, Briele HA, Noyes RD et al (2006) Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020. J Clin Oncol 24:4196–4201CrossRefPubMedGoogle Scholar
  6. Datta NR, Bose AK, Kapoor HK, Gupta S (1990) Head and neck cancers: results of thermoradiotherapy versus radiotherapy. Int J Hyperthermia 6:479–486CrossRefPubMedGoogle Scholar
  7. De Haas-Kock DF, Buijsen J, Pijls-Johannesma M, Lutgens L, Lammering G, van Mastrigt GA et al (2009) Concomitant hyperthermia and radiation therapy for treating locally advanced rectal cancer. Cochrane Database Syst Rev (3):CD006269Google Scholar
  8. Dresen RC, Gosens MJ, Martijn H, Nieuwenhuijzen GA, Creemers GJ, Daniels-Gooszen AW et al (2008) Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancer. Ann Surg Oncol 15:1937–1947CrossRefPubMedPubMedCentralGoogle Scholar
  9. Franckena M, De Wit R, Ansink AC, Notenboom A, Canters RA, Fatehi D et al (2007) Weekly systemic cisplatin plus locoregional hyperthermia: an effective treatment for patients with recurrent cervical carcinoma in a previously irradiated area. Int J Hyperthermia 23:443–450CrossRefPubMedGoogle Scholar
  10. Franckena M, Stalpers LJ, Koper PC, Wiggenraad RG, Hoogenraad WJ, van Dijk JD et al (2008) Long-term improvement in treatment outcome after radiotherapy and hyperthermia in locoregionally advanced cervix cancer: an update of the Dutch Deep Hyperthermia Trial. Int J Radiat Oncol Biol Phys 70:1176–1182CrossRefPubMedGoogle Scholar
  11. Franckena M, Lutgens LC, Koper PC, Kleynen CE, van der Steen-Banasik EM, Jobsen JJ et al (2009) Radiotherapy and hyperthermia for treatment of primary locally advanced cervix cancer: results in 378 patients. Int J Radiat Oncol Biol Phys 73:242–250CrossRefPubMedGoogle Scholar
  12. Gani C, Schroeder C, Heinrich V, Spillner P, Lamprecht U, Berger B et al (2016) Long-term local control and survival after preoperative radiochemotherapy in combination with deep regional hyperthermia in locally advanced rectal cancer. Int J Hyperthermia 1–6Google Scholar
  13. Geiger M, Strnad V, Lotter M, Sauer R (2002) Pulsed-dose rate brachytherapy with concomitant chemotherapy and interstitial hyperthermia in patients with recurrent head-and-neck cancer. Brachytherapy 1:149–153CrossRefPubMedGoogle Scholar
  14. Gellermann J, Wlodarczyk W, Hildebrandt B, Ganter H, Nicolau A, Rau B et al (2005) Noninvasive magnetic resonance thermography of recurrent rectal carcinoma in a 1.5 Tesla hybrid system. Cancer Res 65:5872–5880CrossRefPubMedGoogle Scholar
  15. Gellermann J, Hildebrandt B, Issels R, Ganter H, Wlodarczyk W, Budach V et al (2006) Noninvasive magnetic resonance thermography of soft tissue sarcomas during regional hyperthermia: correlation with response and direct thermometry. Cancer 107:1373–1382CrossRefPubMedGoogle Scholar
  16. Heijkoop ST, van Doorn HC, Stalpers LJ, Boere IA, van der Velden J, Franckena M et al (2014) Results of concurrent chemotherapy and hyperthermia in patients with recurrent cervical cancer after previous chemoradiation. Int J Hyperthermia 30:6–10CrossRefPubMedGoogle Scholar
  17. Hildebrandt B, Wust P, Drager J, Ludemann L, Sreenivasa G, Tullius SG et al (2004) Regional pelvic hyperthermia as an adjunct to chemotherapy (oxaliplatin, folinic acid, 5-fluorouracil) in pre-irradiated patients with locally recurrent rectal cancer: a pilot study. Int J Hyperthermia 20:359–369CrossRefPubMedGoogle Scholar
  18. Hildebrandt B, Hegewisch-Becker S, Kerner T, Nierhaus A, Bakhshandeh-Bath A, Janni W et al (2005) Current status of radiant whole-body hyperthermia at temperatures >41.5 degrees C and practical guidelines for the treatment of adults. The German ‘Interdisciplinary Working Group on Hyperthermia’. Int J Hyperthermia 21:169–183CrossRefPubMedGoogle Scholar
  19. Issels RD (2008) Regional hyperthermia in high-risk soft tissue sarcomas. Curr Opin Oncol 20:438–443CrossRefPubMedGoogle Scholar
  20. Issels RD, Lindner LH, Verweij J, Wust P, Reichardt P, Schem BC et al (2010) Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncol 11:561–570CrossRefPubMedPubMedCentralGoogle Scholar
  21. Jones EL, Oleson JR, Prosnitz LR, Samulski TV, Vujaskovic Z, Yu D et al (2005) Randomized trial of hyperthermia and radiation for superficial tumors. J Clin Oncol 23:3079–3085CrossRefPubMedGoogle Scholar
  22. Juffermans JH, Hanssens PE, van Putten WL, van Rhoon GC, van Der Zee J (2003) Reirradiation and hyperthermia in rectal carcinoma: a retrospective study on palliative effect. Cancer 98:1759–1766CrossRefPubMedGoogle Scholar
  23. Kouloulias V, Plataniotis G, Kouvaris J, Dardoufas C, Gennatas C, Uzunoglu N et al (2005) Chemoradiotherapy combined with intracavitary hyperthermia for anal cancer: feasibility and long-term results from a phase II randomized trial. Am J Clin Oncol 28:91–99CrossRefPubMedGoogle Scholar
  24. Kouloulias V, Triantopoulou S, Uzunoglou N, Pistevou-Gompaki K, Barich A, Zygogianni A et al (2015) Hyperthermia is now included in the NCCN clinical practice guidelines for breast cancer recurrences: an analysis of existing data. Breast Care 10:109–116CrossRefPubMedPubMedCentralGoogle Scholar
  25. Linthorst M, van Geel AN, Baaijens M, Ameziane A, Ghidey W, van Rhoon GC et al (2013) Re-irradiation and hyperthermia after surgery for recurrent breast cancer. Radiother Oncol 109:188–193CrossRefPubMedGoogle Scholar
  26. Linthorst M, Baaijens M, Wiggenraad R, Creutzberg C, Ghidey W, van Rhoon GC et al (2015) Local control rate after the combination of re-irradiation and hyperthermia for irresectable recurrent breast cancer: results in 248 patients. Radiother Oncol 117:217–222CrossRefPubMedGoogle Scholar
  27. Lutgens L, van der Zee J, Pijls-Johannesma M, De Haas-Kock DF, Buijsen J, Mastrigt GA et al (2010) Combined use of hyperthermia and radiation therapy for treating locally advanced cervix carcinoma. Cochrane Database Syst Rev (3):CD006377Google Scholar
  28. Milani V, Pazos M, Issels RD, Buecklein V, Rahman S, Tschoep K et al (2008) Radiochemotherapy in combination with regional hyperthermia in preirradiated patients with recurrent rectal cancer. Strahlenther Onkol 184:163–168CrossRefPubMedGoogle Scholar
  29. Mochiki E, Shioya M, Sakurai H, Andoh H, Ohno T, Aihara R et al (2007) Feasibility study of postoperative intraperitoneal hyperthermochemotherapy by radiofrequency capacitive heating system for advanced gastric cancer with peritoneal seeding. Int J Hyperthermia 23:493–500CrossRefPubMedGoogle Scholar
  30. Oldenborg S, Griesdoorn V, van Os R, Kusumanto YH, Oei BS, Venselaar JL et al (2015) Reirradiation and hyperthermia for irresectable locoregional recurrent breast cancer in previously irradiated area: size matters. Radiother Oncol 117:223–228CrossRefPubMedGoogle Scholar
  31. Ott OJ, Rodel C, Weiss C, Wittlinger M, Krause FS, Dunst J et al (2009) Radiochemotherapy for bladder cancer. Clin Oncol (R Coll Radiol) 21:557–565CrossRefGoogle Scholar
  32. Overgaard J, Gonzalez Gonzalez D, Hulshof MC, Arcangeli G, Dahl O, Mella O et al (1995) Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. Eur Soc Hyperther Oncol Lancet 345:540–543Google Scholar
  33. Rau B, Benhidjeb T, Wust P, Schlag PM (2002) Stellenwert der hyperthermie für die chirurgische onkologie (German). Viszeralchirurgie 37:379–384Google Scholar
  34. Rietbroek RC, Schilthuis MS, Bakker PJ, van Dijk JD, Postma AJ, Gonzalez Gonzalez D et al (1997) Phase II trial of weekly locoregional hyperthermia and cisplatin in patients with a previously irradiated recurrent carcinoma of the uterine cervix. Cancer 79:935–943CrossRefPubMedGoogle Scholar
  35. Schaffer M, Krych M, Pachmann S, Abdel-Rahman S, Schaffer PM, Ertl-Wagner B et al (2003) Feasibility and morbidity of combined hyperthermia and radiochemotherapy in recurrent rectal cancer – preliminary results. Onkologie 26:120–124PubMedGoogle Scholar
  36. Schlemmer M, Lindner LH, Abdel-Rahman S, Issels RD (2004) Principles, technology and indication of hyperthermia and part body hyperthermia. Radiologe 44:301–309CrossRefPubMedGoogle Scholar
  37. Schroeder C, Gani C, Lamprecht U, von Weyhern CH, Weinmann M, Bamberg M et al (2012) Pathological complete response and sphincter-sparing surgery after neoadjuvant radiochemotherapy with regional hyperthermia for locally advanced rectal cancer compared with radiochemotherapy alone. Int J Hyperthermia 28:707–714CrossRefPubMedGoogle Scholar
  38. Sneed PK, Stauffer PR, McDermott MW, Diederich CJ, Lamborn KR, Prados MD et al (1998) Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme. Int J Radiat Oncol Biol Phys 40:287–295CrossRefPubMedGoogle Scholar
  39. Strnad V, Lotter M, Kreppner S, Fietkau R (2015) Reirradiation for recurrent head and neck cancer with salvage interstitial pulsed-dose-rate brachytherapy: long-term results. Strahlenther Onkol 191:495–500CrossRefPubMedGoogle Scholar
  40. Tanis PJ, Doeksen A, van Lanschot JJ (2013) Intentionally curative treatment of locally recurrent rectal cancer: a systematic review. Can J Surg 56:135–144CrossRefPubMedPubMedCentralGoogle Scholar
  41. Tilly W, Gellermann J, Graf R, Hildebrandt B, Weissbach L, Budach V et al (2005) Regional hyperthermia in conjunction with definitive radiotherapy against recurrent or locally advanced prostate cancer T3 pN0 M0. Strahlenther Onkol 181:35–41CrossRefPubMedGoogle Scholar
  42. Valdagni R, Amichetti M (1994) Report of long-term follow-up in a randomized trial comparing radiation therapy and radiation therapy plus hyperthermia to metastatic lymph nodes in stage IV head and neck patients. Int J Radiat Oncol Biol Phys 28:163–169CrossRefPubMedGoogle Scholar
  43. van der Zee J, Gonzalez Gonzalez D, van Rhoon GC, van Dijk JD, van Putten WL, Hart AA (2000) Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 355:1119–1125CrossRefPubMedGoogle Scholar
  44. van Meerten E, Franckena M, Wiemer E, van Doorn L, Kraan J, Westermann A et al (2015) Phase I study of cisplatin, hyperthermia, and lapatinib in patients with recurrent carcinoma of the uterine cervix in a previously irradiated area. Oncologist 20:241–242CrossRefPubMedPubMedCentralGoogle Scholar
  45. Vernon CC, Hand JW, Field SB, Machin D, Whaley JB, van der Zee J et al (1996) Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International Collaborative Hyperthermia Group. Int J Radiat Oncol Biol Phys 35:731–744CrossRefPubMedGoogle Scholar
  46. Verwaal VJ, Bruin S, Boot H, van Slooten G, van Tinteren H (2008) 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol 15:2426–2432CrossRefPubMedGoogle Scholar
  47. Wiig JN, Larsen SG, Dueland S, Giercksky KE (2005) Clinical outcome in patients with complete pathologic response (pT0) to preoperative irradiation/chemo-irradiation operated for locally advanced or locally recurrent rectal cancer. J Surg Oncol 92:70–75CrossRefPubMedGoogle Scholar
  48. Winter L, Oberacker E, Paul K, Ji Y, Oezerdem C, Ghadjar P et al (2015) Magnetic resonance thermometry: methodology, pitfalls and practical solutions. Int J Hyperthermia 1–13Google Scholar
  49. Wittlinger M, Rodel CM, Weiss C, Krause SF, Kuhn R, Fietkau R et al (2009) Quadrimodal treatment of high-risk T1 and T2 bladder cancer: transurethral tumor resection followed by concurrent radiochemotherapy and regional deep hyperthermia. Radiother Oncol 93:358–363CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  1. 1.Department of Radiation OncologyUniversity Hospital ErlangenErlangenGermany

Personalised recommendations